Overview
At VIBRI, our foundation is built upon decades of scientific rigor and clinical experience. We are proud to be led and supported by a network of highly experienced investigators, some of whom have been at the forefront of clinical research for more than 25 years. This deep-seated expertise allows us to navigate the complexities of drug and vaccine development with confidence and precision.
Our team is proficient across the entire development spectrum, managing trials from early-phase First-in-Human (Phase 1) studies through to large-scale Post-Marketing (Phase 4) research. We have extensive experience with both investigational drugs and vaccines, ensuring that we meet the specific regulatory and operational requirements of each. Beyond our therapeutic breadth, we are adept at conducting research across all age cohorts, successfully managing trials in adults, adolescents, and pediatric populations to ensure that medical advancements reach every generation in need.
Furthermore, our research portfolio reflects a versatile capability in tackling a wide array of health challenges. We are deeply experienced in communicable diseases , having conducted numerous trials in areas such as COVID-19, Tuberculosis, Malaria, and HIV. Simultaneously, we have built significant expertise in non-communicable diseases , including complex conditions like Sickle Cell Disease and other metabolic disorders. This unique combination of long-standing experience, demographic reach, and therapeutic diversity positions VIBRI as a comprehensive and trusted partner in the global effort to advance human health.
Researchers
Dr Lucas Tina
Dr Diana Odhiambo
Dr Kenson Kipchumba
Dr Antony Oindo
Dr Joyce Mukami
Dr Kauthar Bagonza
Dr Melanie Miruka
Dr Benard Watta